AN2 Therapeutics, Inc. · NASDAQ:ANTX
AN2 Therapeutics, Inc. shareholders
As of Sep 30, 2026, 84 institutions reported holding AN2 Therapeutics, Inc., 70.9% of its shares. Largest: Vivo Capital, LLC, Commodore Capital LP and Millennium. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of AN2 Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vivo Capital, LLC | 3.15M | 8.3% | no change | Nov 13, 2026 |
| Commodore Capital LP | 2.93M | 7.7% | no change | Nov 16, 2026 |
| Millennium | 2.48M | 6.5% | +158K | Nov 16, 2026 |
| BlackRock | 1.77M | 4.7% | +106K | Nov 13, 2026 |
| Spruce Street Capital LP | 1.75M | 4.6% | +90,938 | Nov 13, 2026 |
| Vanguard | 1.63M | 4.3% | +6,381 | Nov 13, 2026 |
| Acorn Capital Advisors, LLC | 1.3M | 3.4% | new | Nov 16, 2026 |
| Adage Capital Partners Gp, L.L.C. | 1M | 2.6% | no change | Nov 16, 2026 |
| Citadel | 984K | 2.6% | +32,083 | Nov 16, 2026 |
| Boxer Capital Management, LLC | 944K | 2.5% | +195K | Nov 16, 2026 |